Featured
This Practice Advisory was
developed by the American College of Obstetricians and Gynecologists’
Immunization, Infectious Disease, and Public Health Preparedness Expert Work
Group.The American College of
Obstetricians and Gynecologists (ACOG) recommends that pregnant
individuals should have access to COVID-19 vaccines.
While limited, cu...
Gamaleya Research Institute of Russia on August 11 became the first
country in the world to have registered a vaccine against the coronavirus - Sputnik V which is Adeno-based Non-replicating
viral vector. It is a combination of two adenoviruses, Ad5 and Ad26, both
engineered with a coronavirus gene.
“The vaccination of first...
Oxford researchers say having
AstraZeneca then Pfizer vaccine is almost as potent as two shots of Pfizer.Scientists in Oxford looked at
the impact of a mix-and-match approach to vaccinations where people were given
either the standard two shots of Oxford/AstraZeneca or Pfizer/BioNTech
vaccine, or a combination of the two. Mixed schedules involv...
More good news! In addition to last week’s announcement of very high (90%) COVID-19 vaccine efficacy emerging from the first interim analysis of a phase 3 trial [1], we received word that a second vaccine had similar initial efficacy at 94.5%.[2] Both of these candidates use an mRNA platform, a novel approach to human vaccines. Th...
Answers of your Queries about Covid Vaccine.Questions regarding Vaccine administration and safety.
COVID-19 Vaccine FAQs from
Patient’s to Healthcare Professionals.Questions regarding Vaccine Indications.
South Africa has put its rollout of the Oxford-AstraZeneca
vaccine on hold after a study showed "disappointing" results against
its new Covid variant.
Scientists say the variant accounts for 90% of new Covid
cases in South Africa.
The trial, involving some 2,000 people, found
that the vaccine offered "minim...
Novavax COVID-19 Vaccine has been
shown to be 89% effective in large-scale UK trials.
First to Demonstrate Clinical
Efficacy Against COVID-19 and Both UK and South Africa Variants.
The Joint Committee on Vaccination
and Immunisation has decided that people who are at risk because of a heart
condition should be among those who are prioritised to receive the vaccine.
The AstraZeneca-Oxford vaccine is
a recombinant adenoviral vector vaccine. Recombinant vaccines use a small piece
of genetic material from a pathogen, like SARS-CoV-2, to trigger an immune
response. A specific piece of the virus can be targeted, and recombinant
vaccines are generally safe to use in a large population of people—even those
with...
The ChAdOx1 nCoV-19 vaccine was
developed by the University of Oxford and AstraZeneca and manufactured in Serum
Institute of India.
The vaccine works by delivering
the genetic code of the SARS-CoV-2 spike protein to the body’s cells, similarly
to the BNT162b2 vaccine. Once inside the body, the spike protein is produced,
causing the immune...
COVAXIN, India's indigenous
COVID-19 vaccine by Bharat Biotech is developed in collaboration with the
Indian Council of Medical Research (ICMR) - National Institute of Virology
(NIV). The indigenous, inactivated vaccine is developed and manufactured in
Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.
The Drugs Controlle...
